S&P TSX Capped Composite...

US Dollar vs CAD

Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

Get Started

RGLS Regulus Therapeutics Inc

1.65

0.01 (0.61%)

Dec 17 2024 - Closed

Delayed by 15 minutes

Form SC 13G - Statement of Beneficial Ownership by Certain Investors

Regulus Therapeutics (NASDAQ:RGLS)
Historical Stock Chart
From Nov 2024 to Dec 2024

Click Here for more Regulus Therapeutics Charts.

Regulus Therapeutics (NASDAQ:RGLS)
Historical Stock Chart
From Dec 2023 to Dec 2024

Click Here for more Regulus Therapeutics Charts.

Regulus Therapeutics Inc News

Regulus Therapeutics Announces Participation at Upcoming Healthcare Investment Conferences
Tuesday 26 November 2024 (3 weeks ago) • PR Newswire (US)

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
Friday 8 November 2024 (1 month ago) • Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Thursday 7 November 2024 (1 month ago) • Edgar (US Regulatory)

Form 8-K - Current report
Thursday 7 November 2024 (1 month ago) • Edgar (US Regulatory)

Regulus Therapeutics Reports Third Quarter 2024 Financial Results and Recent Updates
Thursday 7 November 2024 (1 month ago) • PR Newswire (US)

Form 8-K - Current report
Thursday 24 October 2024 (2 months ago) • Edgar (US Regulatory)

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
Friday 11 October 2024 (2 months ago) • Edgar (US Regulatory)

Regulus Therapeutics Announces Completion of Enrollment in Fourth Cohort of Phase 1b Multiple-Ascending Dose (MAD) Clinical Trial of RGLS8429 for the Treatment of Patients with Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Tuesday 8 October 2024 (2 months ago) • PR Newswire (US)

Regulus Therapeutics Announces Participation at Two Healthcare Investment Conferences
Wednesday 28 August 2024 (4 months ago) • PR Newswire (US)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Thursday 8 August 2024 (4 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Thursday 8 August 2024 (4 months ago) • Edgar (US Regulatory)

Regulus Therapeutics Reports Second Quarter 2024 Financial Results and Recent Updates
Thursday 8 August 2024 (4 months ago) • PR Newswire (US)

More Regulus Therapeutics Inc News Articles

Metro.tokyo 26r

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions